Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

Tests a stimulation method in people with temporal lobe epilepsy

Tests temporal interference stimulation in adults with temporal lobe epilepsy under electrode monitoring.

Plain-language title generated from the registry record
Registry title: Temporal Interference for Temporal Lobe Epilepsy Under SEEG

Key facts

Where
Xi'an, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07082101, who can take part

Where in China

  • Xijing hospitalXi'an, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Xijing Hospital
Trial code
NCT07082101
Record updated
24 July 2025
Original description
This study evaluates the effect of temporal interference (TI) stimulation on biomarkers in patients with temporal lobe epilepsy (TLE) under stereo-electroencephalography (SEEG), and provides theoretical basis for non-invasive TI treatment of temporal lobe epilepsy.Read full original descriptionShow less

Evaluating Biomarkers of Temporal Interference for Temporal Lobe Epilepsy Under SEEG

This study evaluates the effect of temporal interference (TI) stimulation on biomarkers in patients with temporal lobe epilepsy (TLE) under stereo-electroencephalography (SEEG), and provides theoretical basis for non-invasive TI treatment of temporal lobe epilepsy.

Inclusion: Clinical diagnosis of drug refractory epilepsy and temporal lobe epilepsy; Patients undergoing SEEG; Able to cooperate the treatment and related inspection; Fully understands and signs informed consent.

Exclusion: Patients with temporal plus epilepsy; With other severe disease; In status epilepticus; Pregnancy or lactation women; Unable to tolerate SEEG or TI; At the same time to participate in other clinical trials; Withdraw consent procedure.

ClinicalTrials.gov NCT07082101